• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

113.41 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,200
Open 113.41
Bid (Size) 111.71 (200)
Ask (Size) 113.79 (100)
Prev. Close 113.41
Today's Range 113.41 - 113.41
52wk Range 73.31 - 125.14
Shares Outstanding 2,531,374,696
Dividend Yield 3.00%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally ↗
May 13, 2026
Investors can find much better opportunities. 
Via The Motley Fool
Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
May 13, 2026
Via Investor Brand Network

Performance

YTD
+6.5%
+6.5%
1 Month
-5.5%
-5.5%
3 Month
-4.9%
-4.9%
6 Month
+22.0%
+22.0%
1 Year
+54.4%
+54.4%

More News

Read More
InvestorNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation
May 13, 2026
Via Investor Brand Network
Merck & Co. Inc. (NYSE:MRK): A High Dividend Rating Backed by Strong Profitability and Financial Health ↗
May 09, 2026
Via Chartmill
Merck (NYSE:MRK) Q1 2026 Results Show Underlying Strength Despite Acquisition-Driven Loss ↗
April 30, 2026
Via Chartmill
News headline image
Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
May 13, 2026
From BioMedWire
Via GlobeNewswire
News headline image
1 Dividend ETF Quietly Outperforming the Market Right Now ↗
May 13, 2026
Via The Motley Fool
Topics Artificial Intelligence ETFs Stocks
News headline image
2 Cash-Producing Stocks to Research Further and 1 Facing Challenges
May 13, 2026
Via StockStory
Topics Credit Cards
News headline image
Merck Highlights New Long-Term Data and Advancements Across Broad Oncology Portfolio and Pipeline Research at ASCO 2026
May 12, 2026
From Merck & Co., Inc.
Via Business Wire
News headline image
2 Dividend Stocks to Double Up On Right Now ↗
May 08, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Merck Scientists Publish Landmark Paper on Novel Method for Large-Scale Biocatalytic Synthesis of Investigational Oral PCSK9 Inhibitor, Enlicitide Decanoate
May 07, 2026
From Merck & Co., Inc.
Via Business Wire
News headline image
Eli Lilly Now Has the World's Best-Selling Drug -- But Does That Make the Stock a No-Brainer Buy? ↗
May 07, 2026
Via The Motley Fool
News headline image
The Top 5 Analyst Questions From Merck’s Q1 Earnings Call
May 07, 2026
Via StockStory
Topics Earnings
News headline image
Merck Animal Health Selects Salesforce’s Agentforce Life Sciences for Customer Engagement to Transform Animal Care and Enhance Support Experiences for Employees
May 06, 2026
From Salesforce
Via Business Wire
News headline image
Tempus AI (TEM) Q1 2026 Earnings Transcript ↗
May 05, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Merck Completes Acquisition of Terns Pharmaceuticals, Inc.
May 05, 2026
From Merck & Co., Inc.
Via Business Wire
News headline image
3 Monster Dividend Stocks That Could Pay You Through the Next Decade of Chaos ↗
May 05, 2026
Via The Motley Fool
Topics Artificial Intelligence
What's going on in today's pre-market session: S&P500 movers ↗
May 01, 2026
Via Chartmill
News headline image
MRK Q1 Deep Dive: Oncology Strength, New Launches, and Pipeline Milestones Define Quarter
May 01, 2026
Via StockStory
Top S&P500 movers in Thursday's after hours session ↗
April 30, 2026
Via Chartmill
News headline image
Merck (MRK) Q1 2026 Earnings Call Transcript ↗
April 30, 2026
Via The Motley Fool
Topics Earnings
News headline image
Merck (NYSE:MRK) Surprises With Q1 CY2026 Sales
April 30, 2026
Via StockStory
News headline image
Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones
April 30, 2026
From Merck & Co., Inc.
Via Business Wire
News headline image
Merck (MRK) Q1 Earnings Report Preview: What To Look For
April 28, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Merck’s Playing with Heart Program Teams Up With Professional Baseball Clubs and Baseball Legends to Help Raise Awareness About LDL-C, Called “Bad” Cholesterol, and How It May Impact the Risk of Heart Attack or Stroke
April 28, 2026
From Merck & Co., Inc.
Via Business Wire

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 113.41
When was Merck & Co last traded?
The last trade of Merck & Co was at 05/14/26 07:00 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 287.08B
How many shares of Merck & Co are outstanding?
Merck & Co has 287B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap